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Deletion of the glucocorticoid receptor chaperone Fkbp5 unexpectedly prevents development 
of glucocorticoid-induced cutaneous atrophy via Akt activation
G Baida,1 P Bhalla,1 H Chen,2 W Shou,2 E Sanchez3 and I Budunova1 1 Dermatology, 
Northwestern University, Chicago, IL, 2 Physiology & Pharmacology, University of Toledo 
College of Medicine, Toledo, OH and 3 Wells Center For Pediatric research, Indiana 
University School of Medicine, Indianapolis, IN
Fkbp5 (FK506 binding protein 51) is a known co-chaperone and regulator of glucocorticoid receptor 
(GR), which attenuates GR activity by preventing its nuclear translocation. We and others showed 
previously that Fkbp5 is one of the major GR target genes in epidermis/skin. However, its role in 
clinical effects of topical glucocorticoids in the skin has not been studied. Here, we used Fkbp5 
knockout mice to determine the role of Fkbp5 in the major adverse effect of topical glucocorticoids, 
skin atrophy. We discovered that adult Fkbp5 KO mice have significant skin phenotype including 
epidermal hyperplasia and frequent follicular cysts suggesting the important role of Fkbp5 in epi-
dermis maintenance and hair development. Importantly, Fkbp5 KO animals appeared much more 
resistant to skin atrophy induced by chronic treatment with glucocorticoid fluocinolone acetonide 
(FA) which coincided with protection of CD34+ keratinocyte stem cell population in the hair follicle 
bulge niche in Fkbp5 KO mice. Paradoxically, despite the lack of inhibitory Fkbp5, the activation of 
some GR target genes was attenuated in vitro and in vivo. Among them was REDD1 which we have 
recently identified as a marker of steroid-induced skin atrophy. GR activation by glucocorticoids 
results in both genomic and non-genomic effects, including the inhibition of Akt, a major mediator 
of proliferative signaling in the skin. It is known that Fkbp5 negatively regulates Akt phosphorylation 
and activity. Importantly, we found drastic increases in Akt Ser473 phosphorylation in the epidermis 
of both vehicle- and FA-treated Fkbp5 KO mice compared to wt animals as well as in shFkbp5 
keratinocytes in vitro. Overall, our results suggest that Akt activation maybe responsible for the 
resistance of Fkbp5 KO mice to atrophic effects of topical glucocorticoids.    
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c-Src/Cav1-dependent activation of the EGFR by Dsg2 
KP McGuinn,1 F Cooper,1 DM Brennan-Crispi,1 JK Wahl2 and MG Mahoney1 1 Dermatology 
and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2 Oral Biology, 
University of Nebraska Medical Center, Lincoln, NE
Squamous cell carcinoma (SCC) is the second most common skin cancer and incidence continues 
to rise. Mutations leading to EGFR overexpression and activation contribute to the development 
and progression of SCC. We recently showed that the desmosomal cadherin desmoglein 2 (Dsg2) 
is upregulated in SCC and activates mitogenic signaling including the MAPK/ERK pathway. Here 
we investigate the crosstalk between the EGFR and Dsg2 signaling pathways that may provide a 
mechanism by which Dsg2 stimulates epithelial proliferation, migration and survival. We generated 
stable Dsg2 knockdown in HaCaT cell lines by shRNA and showed that loss of Dsg2 reduced EGFR 
expression and activation in response to EGF ligand. With loss of Dsg2 the level of activated c-Src, 
a non-membrane tyrosine kinase proto-oncogene, was also abrogated. Pharmacological inhibition 
of c-Src with PP2, reduced phosphorylation of EGFR independent of EGF ligand, suggesting EGFR 
activation is mediated in part by c-Src. We recently established Dsg2 binds to caveolin 1 (Cav1), the 
major component of caveolae. These specialized membrane lipid rafts regulate cell communication 
by compartmentalizing signaling proteins. c-Src has been shown to phosphorylate Cav1, which 
in turn binds c-Src rendering it inactive. Here we show that in absence of Dsg2, c-Src and Cav1 
localize to the raft fractions with concomitant increase in phospho-Cav1 indicating c-Src is inactive. 
In the presence of Dsg2, Cav1 is sequestered outside the rafts releasing its negative effects on c-Src, 
thus providing a mechanism for Dsg2 to regulate cell signaling. Perturbation of lipid rafts with the 
cholesterol-chelating agent MβCD disrupted cell-cell adhesion, which was rescued by MAPK/ERK 
and c-Src inhibitors, suggesting that cell adhesion is modulated in part by cell signaling. As such, 
knockdown of Dsg2 also protected cells from MβCD-mediated disadhesion. Taken together, these 
observations suggest that Dsg2 may enhance tumor development by positively regulating EGFR 
level and signaling.    
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Significant birth weight advantage of Melanocortin–1–Receptor variants in humans, an evo-
lutionary pressure?
AC Thomas,1 C Santos,2 GE Moore1 and VA Kinsler1 1 Genetic and Genomic Medicine, 
UCL Institute of Child health, London, United Kingdom and 2 Birth Defects Research Centre, 
Institute of Child Health, London, United Kingdom
The Melanocortin-1-Receptor (MC1R) gene encodes a G-Protein-Coupled Receptor key to the 
production of melanin, and is involved in normal pigmentation, pigmentary disorders including 
melanoma, and opioid receptor pathways. Recent evidence that MC1R variants may play a role in 
fetal growth led us to investigate the effect of this gene on birth weight in a large cohort of healthy 
children. The genotype for previously implicated variants R151C and V92M was established for 9139 
and 962 children respectively from the UK ALSPAC study cohort. This was accompanied by detailed 
maternal phenotyping data. Using linear regression modeling, a striking association was found 
between both variants separately and birth weight (R151C resulted in babies 106.9g heavier with 
a p-value of 0.011, V92M resulted in babies 90.4g heavier with a p-value of 0.035), independent 
of known birth weight modifiers. This strongly suggests that the evolution of these common MC1R 
variants could be in part due to a survival advantage from increased birth weight, independent of 
maximisation of vitamin D production in low UVB areas. Possible mechanisms underlying this effect 
were studied in human tissue, using qRT-PCR of MC1R in 30 term placental samples with matched 
genotype, and in situ hybridisation in human embryonic tissue at different stages. No differences 
were found in placental expression between wild-type and variant genotype. MC1R expression was 
detected in fetal tissue, in areas involved in bone growth and neuronal development, providing a 
tentative mechanism for the effect of genotype on birth weight.    
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A disintegrin and metalloproteinase 17 (ADAM17) dependent EGFR signaling modulates 
epidermal barrier maintenance through PKC 
C Cobzaru, L Bruckner-Tuderman and C Franzke Dermatology, University Medical Center 
Freiburg, Freiburg, Germany
The multilayered epidermis builds a vitally important skin barrier. Weakening of this barrier seems to 
be tightly connected to the pathogenesis of chronic inflammatory skin diseases. We have previously 
shown that conditional keratinocyte specific loss of ADAM17, the principal EGFR ligand sheddase, 
results in postnatal skin barrier defects with decreased transglutaminase (TGM) activity, followed 
by massive immune cell infiltrations. These effects were most likely caused by strongly repressed 
EGFR signaling in the keratinocytes, since in vitro differentiated Adam17-/- and Egfr-/- keratinocytes 
revealed a cell autonomous decrease in TGM1 expression and activity, while TGM activity was 
restored in differentiated Adam17-/- keratinocytes by addition of EGFR ligand TGFα. To identify 
the pathways by which the ADAM17/EGFR axis regulates TGM activity, we have analyzed the 
MAPK, PI3K/Akt and PLC/PKC signaling as well known EGFR downstream pathways. Western blot 
analysis of Adam17-/- keratinocytes and epidermis revealed reduced phosphorylation of ERK and 
PLCγ1 as well as decreased expression of PKCη. Using TGFα-stimulated differentiated Adam17-/- 
keratinocytes as a model for EGFR dependent TGM activity, the addition of either the PLCγ1 inhibitor 
U73122 or the PKC inhibitor bisindolylmaleimide strongly repressed TGM activity. In addition, the 
strongly reduced TGM activity in differentiated Adam17-/- keratinocytes was completely restored by 
treatment with the phorbol ester TPA in vivo and in vitro. Our results suggest the ADAM17/EGFR 
axis as modulator of TGM activity through PLC/PKC signaling and highlight the importance of the 
EGFR/PLC/PKC pathway for terminal differentiation in keratinocytes. These findings may help to 
identify new therapeutic targets for inflammatory skin diseases, like atopic dermatitis or psoriasis.   
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B-Myb Enhances Proliferation and Suppresses Differentiation of Keratinocytes in Three-di-
mensional Cell Culture
H Maruyama,1 Y Ishitsuka,1 Y Fujisawa,1 J Furuta,1 Y Kawachi,1 M Sekido2 and M Fujimoto1 
1 Dermatology, University of Tsukuba, Tsukuba, Japan and 2 Plastic Surgery, University of 
Tsukuba, Tsukuba, Japan
B-Myb (Mybl2) is a member of the Myb gene family of transcription factors involved in the control 
of cell growth, differentiation, and apoptosis. The effects of B-Myb on keratinocyte proliferation 
and differentiation have not yet been clarified. The present study was performed to examine the 
role of B-Myb in proliferation and differentiation of the spontaneously immortalized human skin 
keratinocyte cell line HaCaT and normal human keratinocytes with formation of a stratified epi-
dermoid structure in air-liquid interface 3-dimensional culture. B-Myb was expressed specifically 
in undifferentiated normal keratinocytes and downregulated during differentiation. The constitutive 
overexpression of B-Myb in HaCaT cells during air exposure-induced differentiation resulted in an 
undifferentiated phenotype, i.e., thickening of the stratified layers, suppression of differentiation 
marker expression, and retention of proliferative activity with activation of cell cycle regulatory 
proteins in the S and G2/M phases. In contrast, suppression of B-Myb caused their downregulation 
and constrained proliferation with retention of differentiation capacity. These findings suggested 
that B-Myb may play an important role in maintenance of the undifferentiated phenotype of kera-
tinocytes in the basal epidermal layer.    
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Endocannabinoids and growth factors cross-talk in the process of wound healing
G Cardinali,1 D Kovacs,1 E Flori,1 S Briganti,1 R Bertorelli,2 D Piomelli2 and M Picardo1 1 
Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, 
San Gallicano Dermatologic Institute, Rome, Italy and 2 Drug Discovery and Development, 
Italian Institute of Technology, Genoa, Italy
The interplay among the pathways triggered by growth factors and lipid mediators is crucial in 
the healing process. Among the lipid messengers, the endocannabinoids (eCBs) exert proliferative 
and migratory effects via both their specific G protein-coupled receptors and the trans-activation 
of growth factor tyrosine kinase receptors. To analyse the biological effects induced by the modu-
lation of endogenous eCB levels in the wound repair we used an inhibitor of the fatty-acid amide 
hydrolase, (URB 597), an enzyme that catalyzes the anandamide (AEA) intracellular hydrolysis, on 
human primary cultures of keratinocytes and fibroblasts. The inhibitor (0.1-1.0 μM) induced a dose 
dependent increase of AEA at intracellular and extracellular levels (from 100 to 500 % and from 50 
to 200% respectively). No effect on keratinocyte proliferation, but a decrease (10-40%) of keratin 1 
and an increase (20%) of keratin 16 expression were observed at 1 μM indicating the induction of a 
de-differentiation and activation process. A migration promotion was demonstrated by the scratch 
assay (30-40% reduction area). Increased intracellular levels of AEA induced the phosphorylation 
of the epidermal growth factor receptor (up to 2.3 fold increase). In turn, treatment with epidermal 
growth factor augments the levels of eCBs. Treated fibroblasts displayed a trans-differentiation 
in myofibroblasts with an increased expression of alpha-smooth muscle actin (20-30%) and of 
collagen type I production (20-40%). Moreover an increased hepatocyte growth factor expression 
was detected (40-60%). Our results demonstrate that the signaling pathways mediated by lipids 
and growth factors work in concert favouring cellular processes involved in the wound repair.The 
knowledge of the network generated might open important therapeutic perspectives to specifically 
manage conditions of impaired wound healing.    
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Insulin Activates Phosphoinositide–3–Kinase/ Akt/ Forkhead box-O1 Pathway in SZ95 Sebo-
cytes in Vitro 
Y Mirdamadi,1 A Thielitz,1 A Wiede,1 SR Quist,1 M Lotzing,1 E Papakonstantinou,1 
L Simeoni,2 CC Zouboulis3 and H Gollnick1 1 Department of Dermatology and Venereology, 
Otto-von-Guericke-University Magdeburg, Magdeburg, Germany, 2 Institute of Molecular 
and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany 
and 3 Departments of Dermatology, Venereology, Allergology and Immunology, Dessau 
Medical Center, Dessau, Germany
A recent hypothesis in the pathogenesis of acne suggests that nutrition related acne-inducing factors 
exert their action by reducing nuclear transcription factor Forkhead box-O1 (FoxO1) levels via 
phosphoinositide-3-kinase (PI3K)/ Akt pathway. The aim of our study was to confirm in vitro the yet 
hypothetical nutrigenomic regulation of insulinotropic diet and thereby support the role of FoxO1 
as a key molecule in the acne pathogenesis. SZ95 sebocytes were treated with insulin in a time 
and dose dependent manner and nuclear and cytoplasmic expression levels of p-Akt and p-FoxO1 
were analyzed by western blot. FoxO activity was determined by dual luciferase reporter assay. 
Proliferation of sebocytes was measured by [3H] thymidine incorporation assay and differentiation 
by semiquantitative analysis of lipid droplet accumulation using Oil Red O staining. Western blotting 
results revealed an activation of the PI3K /Akt /FoxO1 pathway with a cytoplasmic up-regulation 
of p-Akt (60 minutes) and p-FoxO1 (90 minutes) after stimulation with 1μM insulin. FoxO activity 
detected after 30, 60 and 90 minutes was decreased upon 1μM and 0.1μM insulin incubations. The 
DNA synthesis was suppressed and in contrast sebocytes differentiation was increased after insulin 
incubation. Our data support the role of insulin as an activator of p-FoxO1 via nuclear mobilization 
of FoxO1 after cytoplasmic activation of PI3K / Akt pathway. We showed FoxO1 acted as a mediator 
for the regulation of insulin-induced effects on sebaceous lipogenesis and proliferation in vitro. Our 
data support the potential role of FoxO1 as a key molecule in pathogenesis of acne.    
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KGF influences EDA+FN production in fibroblasts through the MAPK cascade
B Gubán Konczné,1 K Vas,1 A Bebes,1 G Groma,1 M Széll,2 L Kemény1 and Z Bata-Csorgo1 1 
Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary and 2 
Department of Medical Genetics, University of Szeged, Szeged, Hungary
In our previous work we showed that the fibronectin splice variant extradomain-A (EDA+FN), its 
receptor the alpha5-integrin, the keratinocyte growth factor (KGF, FGF-7), and its receptor (FGFR2) 
are overexpressed in psoriatic uninvolved skin compared to healthy skin. We also found a putative 
autocrine regulatory loop between KGF and EDA+FN in fibroblasts. In our current work we aimed to 
elucidate the signaling mechanisms leading to the KGF mediated changes in EDA+FN expression. For 
that we opted to use inhibitors of the major KGF induced signaling pathways, the mitogen-activated 
protein kinase (MAPK) and the phosphoinositide 3-kinase (Akt) pathways known to act downstream 
of FGFR2. Cultured normal human fibroblasts were treated with human recombinant KGF. We 
carried out RTq-PCR and flow cytometric measurements to analyze EDA+FN production 24 hours 
after applying exogenous KGF and inhibitors of MEK-1 and Akt ½. EDA+FN protein expression 
increased significantly following exogenous KGF treatment (n=7, p<0.01), which was inhibited by 
a specific MEK-1 inhibitor (PD 098059), indicating that MAPK cascade activation is essential for the 
effect (n=7, p<0.05). Blocking the Akt ½ kinase resulted in a notable induction of EDA+FN protein 
expression in fibroblasts (n=6) that was not influenced by the addition of exogenous KGF. These 
data indicate the existence of a previously unknown regulatory feedback loop of KGF in fibroblasts 
affecting EDA+FN production, which may be relevant in psoriasis pathomechanism.    
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Melanocytes: Potential role in psoriasis?
Z Balog, G Groma, A Bebes, L Kemény and Z Bata-Csörgö Department of Dermatology and 
Allergology, University of Szeged, Szeged, Hungary
Immune cells and keratinocytes contribute substantially to the formation of skin lesions in psori-
asis, however the role of melanocytes, another important epidermal resident cell type is not fully 
understood. We showed that the keratinocyte growth factor (KGF) as well as its receptor (FGFR2) 
and the fibronectin (FN1) splice variant EDA+FN, are overexpressed in psoriatic uninvolved skin 
compared to normal skin. Here, we aimed to elucidate whether KGF could influence the expression 
of FN1 and EDA+FN in melanocytes. We determined that melanocytes express the FGFR2IIIb splice 
variant of KGF receptor. We also compared the adhesion ability of cultured human melanocytes 
and peripheral blood mononuclear cells (PBMCs) derived from psoriatic patients to healthy controls. 
Human melanocytes derived from healthy and psoriatic uninvolved skin were cultured in AIMV 
and Keratinocyte –SFM (1:1) media mixture. Melanocytes in 3rd passage were treated with human 
recombinant KGF and after 24 and 48 hours EDA+FN protein levels were measured by flow cytom-
etry. Unlike keratinocytes, melanocytes expressed fibronectin and EDA+FN at comparable levels to 
that of fibroblasts in culture. KGF treatment did not alter FN1, EDA+FN and FGFR2 protein levels, 
as determined by flow cytometry. Cell adherence was measured using xCELLigence real time cell 
detection system with or without FN coating on the culture plates. We observed that melanocytes 
and PBMCs of psoriatic patients showed higher adhesion to fibronectin coated plates compared to 
healthy controls. The altered adhesive properties of melanocytes and PBMCs in psoriatic patients 
may contribute to psoriasis patomechanisms.    
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Neurite elongation of a neuro-sensory cell line was promoted by piperine, an alkaloid extract 
from Piper Nigrum
Z Zarei,2 R Leschiera,1 J Carré,1 L Misery1 and N Lebonvallet1 1 Laboratoire des neurosciences 
de brest, Brest, France and 2 Laboratoire de Biochimie & de Génie Enzymatique des Lipases, 
Sfax, Tunisia
Black pepper or Piper Nigrum is a vegetal of the family of Piperacea. It is traditionally used as a 
flavoring agent in foods. It also has biological activities and is often used in traditional medicine. 
Anti -inflammatory, antioxidant and analgesic activity were recognized. One of its active ingredi-
ents is piperine which is an alkaloid. In this work, neurite outgrowth/elongation of PC12 cells, was 
studied. Piperine was diluted in diméthylsulfoxide. The effects of piperine at the concentrations of 
0.05, 0.5, 5 and 50 mg/mL were assessed. The PC12 cell line, used as a model of sensory neurons, 
was cultured at 50 000 cells per well in medium containing nerve growth factor (NGF) as inductor 
of differentiation. Cells were incubated with piperine for 5 days and then the length of the neurites 
was assessed. We shown that neurite length was increased by 30% with 5 mg / mL of piperine. 
Furthermore, piperine did not induce cytotoxic activity evaluated by lactate deshydrogenase and 
MTT test and perturbation of mitochondrial activity until 50 mg/ml. This work is interesting because 
it highlighted a previously unknown biological property of piperine. We suggested that piperine may 
be tested in circumstances where neuronal growth is inhibited, as for example in burns.    
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The NADPH oxidase isoform 4 controls TGF-beta 1-mediated activation of human dermal 
fibroblasts - a promising new target for the treatment of systemic sclerosis? 
H Dosoki,1 A Stegemann,1 M Taha,2 HJ Schnittler,2 K Hashimoto,3 J Kudla,3 T Luger,1 
C Kerkhoff4 and M Böhm1 1 Department of Dermatology, University of Münster, Münster, 
Germany, 2 Department of Anatomy, University of Münster, Münster, Germany, 3 Institute 
of Biology and Biotechnology of Plants, University of Münster, Münster, Germany and 4 
Department of Biomedical Sciences, University of Osnabrück, Osnabrück, Germany
The pathogenesis of systemic sclerosis is still incompletely understood. Transforming growth fac-
tor-β1 (TGF-beta1)-mediated fibroblast activation plays a central role in this disease and oxidative 
stress has long been implicated in the development of tissue fibrosis. However, the precise molecular 
interplay between TGF-beta1 and oxidative stress generating intracellular enzymes remains largely 
unexplored in human dermal fibroblasts (HDFs). We showed that the NADPH oxidase isoform 
Nox4 is expressed in neonatal and adult HDFs as well as in HDFs from SSc patients. Stimulation 
of normal HDFs with TGF-beta1 resulted in a time- and dose-dependent induction of Nox4 mRNA 
and protein. This effect of TGF-beta1 was mediated by transcriptional induction and associated with 
increased NADPH activity in membrane fractions of HDFs. Immunofluorescence analysis with laser 
confocal microscopy studies further revealed that Nox4 localizes to the endoplasmic reticulum as 
demonstrated by double staining with protein disulfide isomerase. Importantly, pharmacological 
inhibition of NADPH oxidase activity or Nox4-specific knock-down not only suppressed TGF-be-
ta1-mediated expression of collagen type I COL(I) but also induction of both alpha-smooth muscle 
actin and fibronectin 1 in normal HDFs. Likewise, alpha-melanocyte-stimulating hormone, a neu-
ropeptide with antioxidative and antifibrogenic effects, suppressed TGF-beta1-mediated expression 
of Nox4 in HDFs. In summary, our findings highlight Nox4 as a novel intracellular nodal point 
that mediates fibroblast activation. Targeting this oxidative stress-generating enzyme may become 
a novel approach for the treatment of fibrotic skin diseases.    
   
